Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.

Omega-3 Fatty Acids in Early Prevention of Inflammatory Neurodegenerative Disease: A Focus on Alzheimer’s Disease

Open access
Thomas, J., Thomas, C. J., Radcliffe, J., Itsiopoulos, C.·2015·BioMed Research International

Abstract

Alzheimer’s disease (AD) is the leading cause of dementia and the most common neurodegenerative disease in the elderly. Furthermore, AD has provided the most positive indication to support the fact that inflammation contributes to neurodegenerative disease. The exact etiology of AD is unknown, but environmental and genetic factors are thought to contribute, such as advancing age, family history, presence of chronic diseases such as cardiovascular disease (CVD) and diabetes, and poor diet and lifestyle. It is hypothesised that early prevention or management of inflammation could delay the onset or reduce the symptoms of AD. Normal physiological changes to the brain with ageing include depletion of long chain omega-3 fatty acids and brains of AD patients have lower docosahexaenoic acid (DHA) levels. DHA supplementation can reduce markers of inflammation. This review specifically focusses on the evidence in humans from epidemiological, dietary intervention, and supplementation studies, which supports the role of long chain omega-3 fatty acids in the prevention or delay of cognitive decline in AD in its early stages. Longer term trials with long chain omega-3 supplementation in early stage AD are warranted. We also highlight the importance of overall quality and composition of the diet to protect against AD and dementia.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1155/2015/172801

Cites

100 of 100 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Schematic representation showing key pathological features of the degenerative process in Alzheimer's disease (AD). The common characteristics are (1) amyloid-β plaques and (2) neurofibrillary tangles. Neuroinflammatory changes (3) have been identified as the third important component of the disease. Microglia migrate to the plaques and enhance amyloid-β deposition with chronic activation. Brain and neuron images from Wikimedia Commons ( http://upload.wikimedia.org/wikipedia/commons/c/cc/Alzheimers_brain.jpg. http://upload.wikimedia.org/wikipedia/commons/b/be/Derived_Neuron_schema_with_no_labels.svg ).
Figure 1 Schematic representation showing key pathological features of the degenerative process in Alzheimer's disease (AD). The common characteristics are (1) amyloid-β plaques and (2) neurofibrillary tangles. Neuroinflammatory changes (3) have been identified as the third important component of the disease. Microglia migrate to the plaques and enhance amyloid-β deposition with chronic activation. Brain and neuron images from Wikimedia Commons ( http://upload.wikimedia.org/wikipedia/commons/c/cc/Alzheimers_brain.jpg. http://upload.wikimedia.org/wikipedia/commons/b/be/Derived_Neuron_schema_with_no_labels.svg ).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 100 references

Research works printed but not linked: 4

  1. 2009, Current Opinion in Investigational Drugs, 10, 1049
  2. 1990, Upsala Journal of Medical Sciences, Supplement, 97
  3. 2006, Journal of Nutrition, Health and Aging, 10, 386
  4. 2002, Nihon Yakurigaku Zasshi, 120, 54P

Cited by

See all 189

Metadata

Authors
Thomas, J., Thomas, C. J., Radcliffe, J., & Itsiopoulos, C.
Affiliations
La Trobe University (AU)
Corresponding author
Itsiopoulos, C.
Venue
BioMed Research International
Publisher
Wiley
Published
2015
Volume
2015
Pages
1-13
ISSN
  • 1110-7243 (ISSN-L)
  • 2314-6133
  • 2314-6141
OpenAlex
W1938773032
Cited by
173
References
100
Citations by year
2026: 6 · 2025: 18 · 2024: 20 · 2023: 13 · 2022: 18 · 2021: 16 · 2020: 20 · 2019: 19 · 2018: 13 · 2017: 21 · 2016: 8 · 2015: 1
FWCI
1.84
Type
journal article
Language
en
Open access
Locations
  • BioMed Research International (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Minerva Access (University of Melbourne) (submittedVersion, cc-by)
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Keywords
omega-3 fatty acids, Alzheimer's disease, neuroinflammation, docosahexaenoic acid, dietary supplementation, cognitive decline, dementia prevention, brain aging, long-chain polyunsaturated fatty acids, diet quality
MeSH terms
Aging, Alzheimer Disease, Diet, Humans, Fatty Acids, Omega-3, Dietary Supplements, Neurodegenerative Diseases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Omega-3 Fatty Acids in Early Prevention of Inflammatory Neurodegenerative Disease: A Focus on Alzheimer’s Disease. https://app.cochat.ai/papers/10.1155/2015/172801
The paper
Thomas, J., Thomas, C. J., Radcliffe, J., & Itsiopoulos, C. (2015). Omega-3 Fatty Acids in Early Prevention of Inflammatory Neurodegenerative Disease: A Focus on Alzheimer’s Disease. BioMed Research International. https://doi.org/10.1155/2015/172801

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.